SCHEMBL2667007

SCHEMBL2667007

CN/C(C)=C\C(=N)NC(=O)c1cc(O)cc(OC(CF)CF)c1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 2/20 0.32
KCNH2 Q12809 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2669305 0.83 GCK (0.32) GCKKCNH2
SCHEMBL2667101 0.83 GCK (0.40) GCK
SCHEMBL1427026 0.72 CA1 (0.56)
SCHEMBL2666697 0.71 TDP1 (0.33) GCK
SCHEMBL2666549 0.69 GCK (0.38) GCK
SCHEMBL13209318 0.68 GCK (0.34) GCKKCNH2
SCHEMBL13209296 0.67 GCK (0.42) GCK
SCHEMBL13209323 0.67 GCK (0.42) GCK
SCHEMBL1427049 0.65 GCK (0.47) GCKKCNH2
SCHEMBL1426914 0.65 GCK (0.65) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007007041-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2007-01-18 WO disclosed